The popularity of Viagra initially drove a period of growth for major pharmaceutical companies, however recent shifts present a murky picture for shareholders. Lower-cost competitors are eating into revenue, and https://theresannqq343845.prublogger.com/40051418/the-blue-pill-and-big-pharma-a-risky-bet